Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN16331121) titled 'Novel diagnostic pathways for prostate cancer risk assessment' on Sept. 8.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Prostate Cancer Research
Condition:
Early detection and risk stratification of clinically significant prostate cancer
Cancer
Intervention:
Prospective observational cohort study with an embedded paired diagnostic accuracy analysis.
Men aged 45-74 years undergo prostate cancer risk assessment through a pathway incorporating PSA testing. Where pathway criteria are met, Stockholm3 testing is performed to provide additional risk stratification. Participants meeting p...